Clinical Trial: Efficacy and Safety of Avatrombopag for Thrombocytopenia After Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized, Open-Label, Active-Controlled Study (China)

Posted On: 2026-09-07

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Avatrombopag for Thrombocytopenia After Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized, Open-Label, Active-Controlled Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131683

Registration Time: 2026/09/05

Type: Interventional study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341176

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Avatrombopag for Thrombocytopenia After Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized, Open-Label, Active-Controlled Study (China)